Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.42 - $1.48 $438,039 - $1.54 Million
1,042,950 Added 904.91%
1,158,204 $1.7 Million
Q1 2022

May 16, 2022

BUY
$1.06 - $2.68 $122,169 - $308,880
115,254 New
115,254 $133,000
Q3 2020

Nov 16, 2020

SELL
$11.73 - $16.25 $4.09 Million - $5.66 Million
-348,514 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$13.68 - $20.46 $4.43 Million - $6.63 Million
323,871 Added 1314.25%
348,514 $5.6 Million
Q1 2020

May 15, 2020

BUY
$14.83 - $26.72 $365,455 - $658,460
24,643 New
24,643 $382,000
Q3 2019

Nov 14, 2019

SELL
$10.17 - $13.86 $179,531 - $244,670
-17,653 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$11.43 - $15.12 $201,773 - $266,913
17,653 New
17,653 $222,000
Q1 2019

May 15, 2019

SELL
$5.98 - $13.98 $103,454 - $241,854
-17,300 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$5.22 - $10.44 $90,306 - $180,612
17,300 New
17,300 $107,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.